IL-25 signaling is proposed to be involved in infection, asthma and allergy, psoriasis, autoimmunity including inflammatory bowel disease (IBD), rheumatoid arthritis, multiple sclerosis, Sjögren’s Syndrome and cancer (56–59). This evidence concerns the gene IL25 and inflammatory bowel disease.